Dnata:企業のM&A・事業提携・投資動向

◆英語タイトル:Dnata - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1638
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:UAE
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Dnata – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Dnata Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Dnata since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Dnata’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Dnata. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Dnata’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Dnata and its subsidiaries since 2007.
- Information about key financial and legal advisors for Dnata’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Dnata’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 47
Partnership – Overview 47
Partnership – Deal reports 48
DIVESTMENTS 51
Divestments – Overview 51
Divestments – Deal reports 52
PRIVATE EQUITY & OWNERSHIP 54
Private Equity and Ownership – Deal reports 54
APPENDIX 56
Contact Us 56
About MarketLine Financial Deals Database 56
Deal Definition and Methodology 58
About MarketLine 65

List of Tables
Table 1: dnata M&A volume and value trend (2014-YTD2018)
Table 2: dnata M&A activity by geography (2014-YTD2018)
Table 3: dnata partnership volume and value trend (2014-YTD2018)
Table 4: dnata partnership trend by key deal type (2014-YTD2018)
Table 5: dnata divestments volume and value trend (2014-YTD2018)
Table 6: dnata divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: dnata M&A volume and value trend (2014-YTD2018)
Figure 2: dnata M&A activity by geography (2014-YTD2018)
Figure 3: dnata partnership volume and value trend (2014-YTD2018)
Figure 4: dnata partnership trend by key deal type (2014-YTD2018)
Figure 5: dnata divestments volume and value trend (2014-YTD2018)
Figure 6: dnata divestments by geography (2014-YTD2018)

★海外企業調査レポート[Dnata:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • State Atomic Energy Corporation Rosatom-エネルギー分野:企業M&A・提携分析
    Summary State Atomic Energy Corporation Rosatom (ROSATOM), the Russian Federation national nuclear corporation, is a nuclear company that integrates nuclear companies and R&D institutions which operate in the civilian and defense sectors. It provides a variety of nuclear services that range from ura …
  • Essilor International S.A.:企業の戦略・SWOT・財務分析
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GlaxoSmithKline Plc (GSK)-製薬・医療分野:企業M&A・提携分析
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respira …
  • Kinross Gold Corp:企業の戦略・SWOT・財務情報
    Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • FXI, Inc.:企業の戦略的SWOT分析
    FXI, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Athabasca Oil Corp (ATH):石油・ガス:M&Aディール及び事業提携情報
    Summary Athabasca Oil Corp (Athabasca) is an upstream energy company which focuses on exploration, development and production of bitumen, light oil and liquids-rich natural gas from oil sands and related assets. The company employs multi-stage fracturing and horizontal drilling technology from uncon …
  • Kering SA:戦略・SWOT・企業財務分析
    Kering SA - Strategy, SWOT and Corporate Finance Report Summary Kering SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • China Billion Resources Limited:企業の戦略・SWOT・財務情報
    China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report Summary China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Shire Plc (SHP)-製薬・医療分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Hasbro Inc (HAS):企業の財務・戦略的SWOT分析
    Hasbro Inc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • American Airlines Group Inc.:企業の戦略・SWOT・財務分析
    American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report Summary American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Generali Deutschland AG:企業の戦略・SWOT・財務情報
    Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Azul SA (AZUL):企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Cantel Medical Corp. (CMD)-医療機器分野:企業M&A・提携分析
    Summary Cantel Medical Corp. (Cantel) is a manufacturer and distributor of infection prevention and control products and services to the healthcare market. The company’s product portfolio includes water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reproc …
  • Fondation MEDINA-製薬・医療分野:企業M&A・提携分析
    Summary Fondation MEDINA (MEDINA) is a research organization that discovers biologically active molecules and drug candidates for unmet medical needs. The organization’s services include access to natural products libraries, drug discovery contract research with its high throughput screening platfor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆